CD8A and neoplasm: Multivariate analysis including the known prognostic factors age, FIGO stage and residual tumor showed trends toward an independent impact of CD8/TLS/LA-positivity on OS and PFS in PTs only (p = 0.016, HR 0.44, 95%CI 0.22–0.86 and p = 0.035, HR 0.52, 95%CI 0.28–0.96 respectively, Supplementary Table 4).